[18F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review

Malene Grubbe Hildebrandt; Annette Raskov Kodahl; Dorte Teilmann-Jørgensen; Ole Mogensen; Pernille Tine Jensen

doi:10.1016/j.cpet.2014.09.007

[¹⁸F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review

Malene Grubbe Hildebrandt, Annette Raskov Kodahl, Dorte Teilmann-Jørgensen, Ole Mogensen, Pernille Tine Jensen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

In this literature review, an update is provided on the role of [(18)F]fluorodeoxyglucose PET/computed tomography in different clinical settings of the 4 most frequent female-specific cancer types: breast, endometrial, ovarian, and cervical cancer. The most recent knowledge regarding primary diagnosis, staging, response evaluation, prognostic and predictive values, recurrence detection, and radiotherapy planning is evaluated, including, when clinically relevant, considerations with respect to the epidemiology, treatment, and course of the diseases.

Originalsprog	Engelsk
Tidsskrift	P E T Clinics
Vol/bind	10
Udgave nummer	1
Sider (fra-til)	89-104
ISSN	1556-8598
DOI	https://doi.org/10.1016/j.cpet.2014.09.007
Status	Udgivet - 2015

Emneord

Breast Neoplasms/di [Diagnosis] computer assisted tomography *diagnostic use female Genital Neoplasms, Female/di [Diagnosis] human multimodal imaging positron emission tomography *procedures fluorodeoxyglucose f 18 radiopharmaceutical agent

Dokumenter og links

10.1016/j.cpet.2014.09.007

Citationsformater

@article{78af712433cf4b06a1d016d1ed13c8d8,

title = "[18F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review",

abstract = "In this literature review, an update is provided on the role of [(18)F]fluorodeoxyglucose PET/computed tomography in different clinical settings of the 4 most frequent female-specific cancer types: breast, endometrial, ovarian, and cervical cancer. The most recent knowledge regarding primary diagnosis, staging, response evaluation, prognostic and predictive values, recurrence detection, and radiotherapy planning is evaluated, including, when clinically relevant, considerations with respect to the epidemiology, treatment, and course of the diseases.",

keywords = "Breast Neoplasms/di [Diagnosis] computer assisted tomography *diagnostic use female Genital Neoplasms, Female/di [Diagnosis] human multimodal imaging positron emission tomography *procedures fluorodeoxyglucose f 18 radiopharmaceutical agent, Breast Neoplasms/diagnosis, Female, Fluorodeoxyglucose F18, Genital Neoplasms, Female/diagnosis, Humans, Multimodal Imaging/methods, Positron-Emission Tomography/methods, Radiopharmaceuticals, Tomography, X-Ray Computed/methods",

author = "Hildebrandt, {Malene Grubbe} and Kodahl, {Annette Raskov} and Dorte Teilmann-J{\o}rgensen and Ole Mogensen and Jensen, {Pernille Tine}",

year = "2015",

doi = "10.1016/j.cpet.2014.09.007",

language = "English",

volume = "10",

pages = "89--104",

journal = "P E T Clinics",

issn = "1556-8598",

publisher = "W.B.Saunders Co.",

number = "1",

}

TY - JOUR

T1 - [18F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers

T2 - a literature review

AU - Hildebrandt, Malene Grubbe

AU - Kodahl, Annette Raskov

AU - Teilmann-Jørgensen, Dorte

AU - Mogensen, Ole

AU - Jensen, Pernille Tine

PY - 2015

Y1 - 2015

N2 - In this literature review, an update is provided on the role of [(18)F]fluorodeoxyglucose PET/computed tomography in different clinical settings of the 4 most frequent female-specific cancer types: breast, endometrial, ovarian, and cervical cancer. The most recent knowledge regarding primary diagnosis, staging, response evaluation, prognostic and predictive values, recurrence detection, and radiotherapy planning is evaluated, including, when clinically relevant, considerations with respect to the epidemiology, treatment, and course of the diseases.

AB - In this literature review, an update is provided on the role of [(18)F]fluorodeoxyglucose PET/computed tomography in different clinical settings of the 4 most frequent female-specific cancer types: breast, endometrial, ovarian, and cervical cancer. The most recent knowledge regarding primary diagnosis, staging, response evaluation, prognostic and predictive values, recurrence detection, and radiotherapy planning is evaluated, including, when clinically relevant, considerations with respect to the epidemiology, treatment, and course of the diseases.

KW - Breast Neoplasms/di [Diagnosis] computer assisted tomography diagnostic use female Genital Neoplasms, Female/di [Diagnosis] human multimodal imaging positron emission tomography procedures fluorodeoxyglucose f 18 radiopharmaceutical agent

KW - Breast Neoplasms/diagnosis

KW - Female

KW - Fluorodeoxyglucose F18

KW - Genital Neoplasms, Female/diagnosis

KW - Humans

KW - Multimodal Imaging/methods

KW - Positron-Emission Tomography/methods

KW - Radiopharmaceuticals

KW - Tomography, X-Ray Computed/methods

U2 - 10.1016/j.cpet.2014.09.007

DO - 10.1016/j.cpet.2014.09.007

M3 - Journal article

C2 - 25455882

SN - 1556-8598

VL - 10

SP - 89

EP - 104

JO - P E T Clinics

JF - P E T Clinics

IS - 1

ER -